from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2514c/-

LFCtreatmentdescriptionclass of inhibitor

0.137

Amikacinug/mL Amikacintranslation

0.038

Cap5-10ug/mL Capreomycintranslation

-0.374

Rox10-50 ug/mL Roxithromycintranslation

-0.382

SM2-5 ug/mL Streptomycintranslation

0.054

Tet5-10 ug/mL Tetracyclinetranslation

0.246

Rif0.2-5ug/mL Rifampicintranscription

0.387

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.340

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.301

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.524

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.498

Clofazimine10-13 ug/mL Clofaziminerespiration

0.070

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.555

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.324

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.641

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.218

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.163

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.248

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.747

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.215

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.027

KCN5-20 ug/mL Potassium cyaniderespiration

-0.362

NaN30.2-2 mM Sodium aziderespiration

-0.867

Nigericin50 uM Nigericinrespiration

0.522

TRC10-150 ug/mL Triclosanrespiration

0.188

TRZ10-25 ug/mL Thioridazinerespiration

0.631

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.148

menadione6-10 ug/mL Menadionerespiration

0.271

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.367

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.273

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.180

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.692

NRP_1Non-replicating persistence stage 1dosRassociated

-1.003

Amp0.2mg/mL AmpicillincellWall

-0.167

Cephalexin20-100 ug/mL CephalexincellWall

1.856

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.597

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.479

EMB10-20 ug/mL EthambutolcellWall

-0.780

Eta12-40 ug/mL EthionamidecellWall

-1.068

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.437

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.027

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.276

BZA0.12 mg/mL BenzamidearomaticAmides

-0.017

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.495

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.865

H2O24 mM hydrogen peroxideDNAdamaging

-0.015

Levo10 ug/mL LevofloxacinDNAdamaging

-0.073

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.238

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.352

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.117

UVUV-irradiationDNAdamaging

1.844

ARP41-4 ug/mL Antitubercular compound ARP4?

0.453

Antimycin12.5-50 ug/mL Antimycin A?

0.085

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.547

PA_110-50 ug/mL Antitubercular compound PA-1?

0.366

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.311

PA8240.2-2 ug/mL PA-824?

0.734

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.035

Verapamil50 uM Verapamil?

0.570

mercaptoethanol2 mM 2-Mercaptoethanol?

0.139

methoxatin10-20 ug/mL Methoxatin?